Background: Alzheimer's disease (AD) is a progressive neurodegenerative disorder. Identifying specific composite plasma markers is crucial for early detection and intervention.Method: We analyzed 133
After post-processing, the concentrations were computed by LCModel and summarized in this file prior to any statistical analyses. FPxx-y indicates subject xx and measurement y. (XLSX)